53
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A rapid and highly sensitive HILIC-HPLC based analytical assay method for quantification of azacitidine and venetoclax in a single run

, & ORCID Icon

References

  • Acute Leukemias XIII. Abstracts of Acute Leukemias XIII: biology and treatment strategies. Ann. Hematol. 2011, 90, 25–76. DOI: 10.1007/s00277-011-1158-7.
  • De Kouchkovsky, I.; Abdul-Hay, M. Acute Myeloid Leukemia: A Comprehensive Review and 2016 Update. Blood Cancer J. 2016, 6, e441. DOI: 10.1038/bcj.2016.50.
  • Roberts, A. W.; Davids, M. S.; Pagel, J. M.; Kahl, B. S.; Puvvada, S. D.; Gerecitano, J. F.; Kipps, T. J.; Anderson, M. A.; Brown, J. R.; Gressick, L.; et al. Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. N Engl. J. Med. 2016, 374, 311–322. DOI: 10.1056/NEJMoa1513257.
  • Vakiti, A.; Mewawalla, P. Acute Myeloid Leukemia. [Updated 2023 Aug 8]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan. https://www.ncbi.nlm.nih.gov/books/NBK507875/.
  • Eyre, T. A.; Roeker, L. E.; Fox, C. P.; Gohill, S. H.; Walewska, R.; Walter, H. S.; Forconi, F.; Broom, A.; Arumainathan, A.; Brander, D. M.; et al. The Efficacy and Safety of Venetoclax Therapy in Elderly Patients with Relapsed, Refractory Chronic Lymphocytic Leukaemia. Br. J. Haematol. 2020, 188, 918–923. DOI: 10.1111/bjh.16271.
  • Deeks, E. D. Venetoclax: First Global Approval. Drugs 2016, 76, 979–987. DOI: 10.1007/s40265-016-0596-x.
  • Wei, A. H.; Döhner, H.; Pocock, C.; Montesinos, P.; Afanasyev, B.; Dombret, H.; Ravandi, F.; Sayar, H.; Jang, J.-H.; Porkka, K.; et al. Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission. N Engl. J. Med. 2020, 383, 2526–2537. DOI: 10.1056/NEJMoa2004444.
  • Müller, A.; Florek, M. 5-Azacytidine/Azacitidine. Recent Results Cancer Res 2010, 184, 159–170. DOI: 10.1007/978-3-642-01222-8_11.
  • A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Induction Chemotherapy for Newly Diagnosed Fit Adults With Acute Myeloid Leukemia. 2022. https://classic.clinicaltrials.gov/ct2/show/NCT04801797.
  • Ivanov, V.; Yeh, S.-P.; Mayer, J.; Saini, L.; Unal, A.; Boyiadzis, M.; Hoffman, D. M.; Kang, K.; Addo, S. N.; Mendes, W. L.; et al. Design of the VIALE-M Phase III Trial of Venetoclax and Oral Azacitidine Maintenance Therapy in Acute Myeloid Leukemia. Future Oncol. 2022, 18, 2879–2889. DOI: 10.2217/fon-2022-0450.
  • Shallis, R. M.; Podoltsev, N. A. Maintenance Therapy for Acute Myeloid Leukemia: sustaining the Pursuit for Sustained Remission. Curr. Opin. Hematol. 2021, 28, 110–121. DOI: 10.1097/MOH.0000000000000637.
  • Qu, W.; Lu, J.; Ji, Y.; He, Z.; Hou, M.; Li, D.; Yang, Y.; Liu, D.; Chen, S. Successful Use of Palbociclib Combined with Venetoclax and Azacitidine in an Adult with Refractory/Relapsed Therapy-Related Acute Myeloid Leukemia. Cancer Chemother. Pharmacol. 2024, 1–5. DOI: 10.1007/s00280-024-04642-y.
  • DiNardo, C. D.; Jonas, B. A.; Pullarkat, V.; Thirman, M. J.; Garcia, J. S.; Wei, A. H.; Konopleva, M.; Döhner, H.; Letai, A.; Fenaux, P.; et al. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl. J. Med. 2020, 383, 617–629. DOI: 10.1056/NEJMoa2012971.
  • A Synergistic Chemometric Combination for Whiteness and Greenness Assessed HPLC-Dad Assay of Aqueous Extracts of Ivy and Thyme and Potassium Sorbate in a Syrup Formula. Microchem. J. 2024, 196, 109616. DOI: 10.1016/j.microc.2023.109616.
  • Development of Validated Methods for the Simultaneous Quantification of Finasteride and Tadalafil in Newly Launched FDA-Approved Therapeutic Combination: greenness Assessment Using AGP, Analytical Eco-Scale, and GAPI Tools. RSC Adv. 2023, 13, 11817–11825. DOI: 10.1039/D3RA01437A.
  • Hantzsch Pre-Column Derivatization for Simultaneous Determination of Alendronate Sodium and Its Pharmacopoeial Related Impurity: Comparative Study with Synchronous Fluorometry Using Fluorescamine. “ Journal of Food and Drug Analysis 2019, 27, 208–220. DOI: 10.1016/j.jfda.2018.05.009.
  • Development of Stability Indicating HPLC-DAD Method for Simultaneous Determination of Mometsone Furoate and Salicylic Acid in Ointment. Anal. Methods 2014, 6, 3410–3419. DOI: 10.1039/c3ay42232a.
  • Iudicello, A.; Genovese, F.; Strusi, V.; Dominici, M.; Ruozi, B. Development and Validation of a New Storage Procedure to Extend the in-Use Stability of Azacitidine in Pharmaceutical Formulations. Pharmaceuticals (Basel) 2021, 14, 943. DOI: 10.3390/ph14090943.
  • Novel, A.; Method, R.-H. A Novel RP-HPLC Method Development and Validation for the Determination of Azacitidine Using Hydrotrophic Solvent by QBD Section A-Research Paper Eur. Chem. Bull. 2023, 4996–5004. DOI: 10.48047/ecb/2023.12.si5a.0409.
  • Anusha, K.; Sowjanya, G. Development and Validation of Stability Indicating RP-HPLC Method and Characterization of Degradation Products of anti-Neoplastic Agent by LCMS-MS. IJPQA. 2023, 14, 867–873. DOI: 10.25258/ijpqa.14.4.05.
  • Žigart, N.; Časar, Z. Development of a Stability-Indicating Analytical Method for Determination of Venetoclax Using AQbD Principles. ACS Omega. 2020, 5, 17726–17742. DOI: 10.1021/ACSOMEGA.0C02338/SUPPLFILE/AO0C02338_SI_001.PDF.
  • Murthy Boddapati, S. N.; Kola, A. E.; Suggisetti, V. K. “Development and Validation of RP-HPLC Method for the Simultaneous Determination of Venetoclax and Obinutuzumab in Bulk and Pharmaceutical Dosage Form,” 2020. [Online]. http://www.sciensage.info.
  • Pokar, D.; Sahu, A. K.; Sengupta, P. LC-Q-TOF-MS Driven Identification of Potential Degradation Impurities of Venetoclax, Mechanistic Explanation on Degradation Pathway and Establishment of a Quantitative Analytical Assay Method. J. Anal. Sci. Technol. 2020, 11, 54. DOI: 10.1186/s40543-020-00252-4.
  • Murakami, H.; Iida, K.; Oda, Y.; Umemura, T.; Nakajima, H.; Esaka, Y.; Inoue, Y.; Teshima, N. Hydrophilic Interaction Chromatography-Type Sorbent Prepared by the Modification of Methacrylate-Base Resin with Polyethyleneimine for Solid-Phase Extraction of Polar Compounds. Anal. Sci. 2023, 39, 375–381. DOI: 10.1007/s44211-022-00250-z.
  • Thermo Scientific HILIC Separations Technical Guide HILIC Separations A Practical Guide to HILIC Mechanisms, Method Development and Troubleshooting. 2014.
  • McCalley, D. V. Understanding and Manipulating the Separation in Hydrophilic Interaction Liquid Chromatography. J. Chromatogr. A 2017, 1523, 49–71. DOI: 10.1016/j.chroma.2017.06.026.
  • Vinodh, M.; Vinayak, M.; Pankaj, P.; Rahul, K.; Renita, M. Analytical Method Development and Validation for Simultaneous Estimation of Artemether and Lumefantrine: In Pure and Pharmaceutical Dosage Form Using RP-HPLC Method. Malays. J. Anal. Sci. 2013, 17, 348–358.
  • Rajput, N.; Soni, F.; Sahu, A. K.; Jadav, T.; Sharma, S.; Sengupta, P. Degradation Kinetics and Characterization of Major Degradants of Binimetinib Employing Liquid Chromatography-High Resolution Mass Spectrometry. J. Pharm. Biomed. Anal. 2022, 215, 114753. DOI: 10.1016/j.jpba.2022.114753.
  • Shabir, G. Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry. J. Validat. Technol. 2004, 10, 314–324.
  • ICH Steering Committee. 1996 ICH Q2B Validation of Analytical Procedures: Methodology, European Agency for the Evaluation of Medicinal Products, International Commission on Harmonisation, London (CPMP/ICH/281/95).
  • Guideline, ICH Harmonised Tripartite. 2005 Validation of Analytical Procedures: text and Methodology Q2 (R1). In International Conference on Harmonization. pp 11–12. Geneva, Switzerland: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
  • Jyothi, V. G. S. S.; Veerabomma, H.; Katta, C.; Madan, J. Computational Quality-by-Design Strategy to Validate High-Performance Liquid Chromatography Method for the Estimation of Meloxicam in Bulk Dosage Forms and Milk Samples. Anal. Sci. 2024, 40, 249–261. DOI: 10.1007/s44211-023-00448-9.
  • Sonawane, D.; Sahu, A. K.; Jadav, T.; Sengupta, P. Establishment of a Rapid and Highly Sensitive Reverse-Phase High-Performance Liquid Chromatography Based Analytical Assay Method for Duvelisib. IJPER. 2022, 56, 287–295. DOI: 10.5530/ijper.56.1.34.
  • Sharma, M. K.; Pandey, K.; Shah, R. P.; Kumar, D.; Sengupta, P. A Mechanistic Explanation on Degradation Behavior of Flibanserin for Identification and Characterization of Its Potential Degradants Using LC-DAD/ESI/APCI-Q-TOF-MS/MS. Microchem. J. 2021, 167, 106281. DOI: 10.1016/j.microc.2021.106281.
  • Li, S.; Jiang, M.; Li, M.; Hu, P.; Xu, M.; Shu, C. Development and Validation of a Simple and Sensitive HPLC Method for the Determination of Related Substances in Regorafenib Tablets. Anal. Sci. 2022, 38, 591–599. DOI: 10.1007/s44211-022-00068-9.
  • Rawat, K.; Srivastava, A.; Tandon, S.; Singh, G. P. Method Validation for Simultaneous Determination of Four Neonicotinoids in Vegetables by Liquid Chromatography. Anal. Sci. 2023, 39, 431–439. DOI: 10.1007/s44211-022-00227-y.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.